Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BMRN 79.30
0.27 (0.3%)

Open: 79.29 High: 79.98 Low: 78.88


External Links

52WL $71.65

The 52 Week Low is $71.65 set on Tue, Nov 3, 2020.

52WH $90.79

The 52 Week High is $90.79 set on Thu, Jan 7, 2021.

ATH $151.75

The All-Time High is $151.75 set on Mon, Jul 20, 2015. The current price, $79.30, is 48% below the All Time High.

52 Week Range

Nov 3, 2020
Jan 7, 2021

BMRN Earnings

Q1 Earnings for Jan, Feb & Mar

Thu, Apr 29, 2021

Since Q1 Earnings Report

BMRN 1.4%

Q2 Earnings for Apr, May & Jun

Wed, Jul 28, 2021

Since Q2 Earnings Report

BMRN 1.2%

BMRN Profile

BioMarin Pharmaceutical trades on the NASDAQ. BMRN's market cap is 14.3 Billion.

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin's Roctavian (hemophilia A gene therapy) and vosoritide (treatment for achondroplasia) are poised to potentially launch in the 2021-22 timeframe.


Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.